If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Roberta Cerutti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial

Fabrizi, F., Cerutti, R., Garcia-Agudo, R., Bellincioni, C., Porata, G., Frontini, G., Aoufi-Rabih, S. & Messa, P., Jan 1 2020, (Accepted/In press) In : Clinics and Research in Hepatology and Gastroenterology.

Research output: Contribution to journalArticle

  • HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population

    Fabrizi, F., Cerutti, R., Nardelli, L., Tripodi, F. & Messa, P., 2020, In : Clinics and Research in Hepatology and Gastroenterology. 44, 1, p. 49-56

    Research output: Contribution to journalArticle

  • La infección por VHB es un factor de riesgo de enfermedad renal crónica: revisión sistemática y metaanálisis

    Translated title of the contribution: HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysisFabrizi, F., Cerutti, R., Donato, F. M. & Messa, P., Jan 1 2020, (Accepted/In press) In : Revista Clinica Espanola.

    Research output: Contribution to journalReview article

  • Direct-acting antiviral agents for HCV-associated glomerular disease and the current evidence

    Fabrizi, F., Cerutti, R., Porata, G., Messa, P. & Ridruejo, E., Dec 1 2019, In : Pathogens. 8, 4, 176.

    Research output: Contribution to journalReview article

    Open Access